“…Thus, identification of dysregulated TK(s) in a specific cancer type and development of TK inhibitors (TKIs) that can potently block activity of the dysregulated TK establish the foundation of modern targeted cancer therapies. The 2018 Tang Prize in Biopharmaceutical Science was awarded to Tony Hunter as well as Brian Druker and John Mendelsohn for their great contributions in discovering oncogene src as a TK and developing small molecule TKIs or therapeutic monoclonal antibodies against receptor TK, respectively.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The scientists who developed these technologies, Katalin Karikó, Drew Weissman, and Pieter Cullis, were awarded the 2022 Tang Prize in Biopharmaceutical Science. In this review, we summarize the principles, safety and efficacy of as well as the immune response to COVID-19 mRNA vaccines. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…When FASEB’s annual meeting was changed to Experimental Biology (EB), I worked with EB to ensure the smooth transition. I organized Tang Prize Lectures which became the highly successful EB plenary lectures. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso